Hyperliquid displays a Head and Shoulder pattern of HYPE token, which indicates a significant price change. The $35.5 neckline is crucial with a target of $12.Hyperliquid displays a Head and Shoulder pattern of HYPE token, which indicates a significant price change. The $35.5 neckline is crucial with a target of $12.

Hyperliquid Price Alert – The Head and Shoulders Pattern Shows a Big Drop

hyperliquid

Ali Martinez, a crypto analyst, recently highlighted a textbook head and shoulders pattern forming on Hyperliquid‘s native token, HYPE, suggesting the digital asset may be preparing for substantial price action. For traders to keep a close eye on the decentralized exchange space, this technical training should be a major boost.

Understanding the Head and Shoulders Signal

The head and shoulders pattern is one of the oldest and most trustworthy reversal signals in technical analysis. There are three peaks, with a central “head” and two lower “shoulders” on either side. The neckline is the line that connects the two shoulders. When the price rises below this neckline, traders typically interpret it as a bearish sign indicating further downside.

According to the chart analysis published on November 21, 2025, HYPE has formed a clear head and shoulders pattern. The head extends to the $58 level, while both shoulders have been developed in the $48 to $50 range. The neckline is located near the $36 to $38 zone, which is also around key support levels where the token made several tests in 2025.

CoinMarketCap’s technical analysts have expressed similar concerns, saying that HYPE is being hammered by two major bears patterns. One of these is the head and shoulders formation, which has a potential target of around $12 if the neckline breaks. They have also declared a death cross signal as an additional warning sign for momentum traders.

Activity of Whales and Market Environment

Hyperliquid has a way to go since November 2024 airdrops provided early backers over 300 million HYPE Token Value at $1.2 billion. The token was launched at $3.20 and hit an all-time high of $59.39 in September 2025 and was attractive to institutional and ordinary investors.

HYPE is down 37% from top with trading at $36-$38. This decline has brought the coin to a crucial point where technical and fundamental signs are advancing. November 29, 2025, token unlock of approximately 10 million HYPE tokens to key contributors makes this period extremely interesting.

Technical patterns tell one story, while on-chain data tells another. Early November saw a massive crypto whale deposit of $25.56 million USDC into Hyperliquid, which has led to a massive deposit. This whale behavior indicates that wealthy investors are looking at the current prices as a source of income rather than a threat.

Bull and Bear Scenarios

Traders who are watching HYPE should prepare for several outcomes. If the head and shoulders pattern indicates a decisive break below the $35.5 neckline, measured move targets could take the price to $21 or even lower. Volume will be crucial to watch since a breakdown on heavy selling volume would have more weight than a gradual decrease.

Similarly, if HYPE can hold above its current support zone and invalidate the pattern by pushing back above $43, it would indicate that buyers have absorbed the selling pressure. The aggressive purchase back program of the platform means that there is a backstop that is not available to many other tokens. Hyperliquid’s technical infrastructure and expanding ecosystem of over 180 projects implies that the basic story holds true regardless of short-term price action.

Conclusion

The discovery of a pattern of head and shoulders in Hyperliquid commences at a rapid pace. The technical warning signs should be respected, but they must be weighed against significant whale accumulation and strong platform fundamentals. In crypto markets, patterns are probabilistic rather than deterministic, and traders would be wise to define their risk parameters clearly prior to entering positions in either direction.

Market Opportunity
Hyperliquid Logo
Hyperliquid Price(HYPE)
$29.83
$29.83$29.83
-4.69%
USD
Hyperliquid (HYPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26